Table 4 Changes in peripheral blood of a patient with subcutaneous and penial nodules and eosinophilia after 3 courses of PZQ.
Date | EOS (*109) | EOS(%) | WBC (*109) | N (%) |
|---|---|---|---|---|
2017.8.17 | 4180 | 32.4 | 12.9 | 27.7 |
2017.8.25 | 4020 | 30.9 | 13.0 | 29.7 |
2017.9.7 | 2910 | 21.6 | 13.5 | 38.6 |
2017.9.19 | 4910 | 26.1 | 18.8 | 39.1 |
2017.10.5 | 2450 | 19.0 | 12.9 | 34.2 |
2017.11.7 | 6020 | 29.8 | 20.2 | 42.8 |
2017.12.19 | 6580 | 39.6 | 16.6 | 29.5 |
2018.1.18 | 760 | 7.2 | 10.6 | 42.7 |
2018.2.22 | 1880 | 17.0 | 11.1 | 33.0 |
2018.5.3 | 3910 | 26.9 | 14.5 | 32.4 |
2018.5.3 | Given a course of triclabendazole | |||
2018.8.16 | 1860 | 11.5 | 16.2 | 49.2 |
2019.2.11 | 4110 | 31.3 | 13.1 | 32.8 |
2019.5.23 | 1350 | 13.2 | 10.2 | 40.8 |
2019.7.11 | 2370 | 19.0 | 12.5 | 40.2 |
